Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02260687
Recruitment Status : Completed
First Posted : October 9, 2014
Last Update Posted : September 19, 2019
Sponsor:
Collaborator:
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2, 2018
Actual Study Completion Date : August 22, 2018